ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $775,496 | +4.4% | 49,082 | 0.0% | 0.63% | +32.2% |
Q2 2023 | $743,101 | -30.4% | 49,082 | -33.3% | 0.48% | -34.6% |
Q1 2023 | $1,066,939 | +7.2% | 73,582 | 0.0% | 0.73% | +6.0% |
Q4 2022 | $994,829 | -55.4% | 73,582 | -48.0% | 0.68% | -51.9% |
Q3 2022 | $2,232,000 | +5.6% | 141,593 | -18.4% | 1.42% | -1.9% |
Q2 2022 | $2,114,000 | +29.7% | 173,582 | 0.0% | 1.45% | +87.8% |
Q1 2022 | $1,630,000 | – | 173,582 | – | 0.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,425,784 | $69,750,000 | 26.57% |
5AM Venture Management, LLC | 4,408,379 | $69,476,000 | 13.31% |
72 Investment Holdings, LLC | 509,023 | $8,022,000 | 6.36% |
TCG Crossover Management, LLC | 642,189 | $10,121,000 | 3.04% |
StepStone Group LP | 761,277 | $11,998,000 | 1.71% |
Nan Fung Group Holdings Ltd | 141,593 | $2,232,000 | 1.42% |
Redmile Group, LLC | 1,954,419 | $30,802,000 | 1.20% |
Baker Brothers Advisors | 4,865,819 | $76,685,000 | 0.50% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,655,000 | 0.04% |
Laurion Capital Management LP | 199,066 | $3,137,000 | 0.02% |